Hims & Hers appoints Deb Autor to board; board expands to ten

Hims & Hers Health, Inc.

Board size increased from 9 to 10; Deb Autor appointed effective Nov 15, 2024.
Autor will serve until 2025 annual meeting; determined independent under NYSE rules.
She enters a one-year consulting agreement with $100,000 fee; standard director comp also applies.
Autor appointed to the Risk Committee along with Christopher Payne, Anja Manuel, Kåre Schultz, and David Wells.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Deb Autor

Director

HIMS · Hims & Hers Health, Inc.

Effective: 2024-11-15
Filed: November 21, 2024, 6:59 PM ET

On November 15, 2024, the board of directors (the “Board”) of Hims & Hers Health, Inc. (the “Company”) increased the size of the Board from nine to ten directors and appointed Deb Autor, 57, to fill the newly created vacancy, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Deb Autor was appointed as Director at Hims & Hers Health, Inc..

Action: appointed
Role: Director

Exact text from the filing

On November 15, 2024, the board of directors (the “Board”) of Hims & Hers Health, Inc. (the “Company”) increased the size of the Board from nine to ten directors and appointed Deb Autor, 57, to fill the newly created vacancy, effective immediately.

View on SEC.gov

Hims & Hers Health, Inc. filing history →

Source: SEC EDGAR

accession 0001773751-24-000371

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.